Stock·NASDAQ·Consumer Defensive
Monster Beverage Corporation (MNST)
- Market cap
- $89.59B
- P/E
- 42.34
- Dividend yield
- 0.00%
- Street target
- $50.00median of 25 analysts
- 52-week range
- $32.94 $50.17
The short version
Where MNST stands today, in four lines, and what CleaRank Financial AI makes of it.
MNST at a glance
Monster Beverage Corporation (MNST): Buy, 74/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($44.76 and $42.64).
- Earnings MNST beat estimates in 4 of its last 7 quarters, yet fell the next day after 1 of those beats.
- Insiders Insiders sold $39.3M and made no open-market purchases over the last 18 months.
- Valuation P/E of 42.3 against 24.2 for the Consumer Defensive sector: a premium to peers (+75%).
Figures as of October 17, 2026.
CleaRank Financial AI
Monster Beverage Corporation (MNST) receives a CleaRank rating of Buy and a model score of 74/100.
Trend is the strongest contributor: the price sits 7.24% above its 200-day average and 2.18% above its 50-day average, and the 50-day average is 4.96% above the 200-day. Valuation pulls the score down the most, with the P/E of 42.34 75.0% above the sector median (a premium to peers) and the P/S of 9.72 341.8% above the sector median. The 50-day average is $44.76 and the 200-day is $42.64. Across the past year, the price climbed 30.36%.
Only on CleaRank
Figures we compute ourselves from MNST's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $45.73 is 2.2% above the 50-day simple moving average of $44.76.Price above its 200-day average ›
The price is 7.2% above the 200-day simple moving average of $42.64.50-day average above the 200-day ›
The 50-day average ($44.76) is 5.0% above the 200-day average ($42.64), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 74% of its 52-week range, between $32.94 and $50.17.
MNST share price
Pick a period: each tab shows how far MNST has moved over it, to the last close.
Today's trading
Where MNST sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
2/4P/E below the sector median ›
The trailing P/E of 42.34 is 75.0% above the Consumer Defensive median of 24.2.P/S below the sector median ›
The price-to-sales ratio of 9.72 is 341.7% above the sector median of 2.2.Profitable over the last 12 months ›
Net income over the last 12 months was $2.1B on revenue of $9.2B, a net margin of 23.1%.Beat estimates in most recent reports ›
MNST beat the EPS estimate in 4 of its last 7 reports.
Key statistics
The headline figures for MNST.
As of October 17, 2026, MNST trades at $45.73, with a market value of $89.59B and a P/E ratio of 42.34.
What the numbers say
CleaRank Financial AI's reading of MNST's valuation, growth and risks.
MNST trades on a trailing P/E of 42.34. That is 75.0% above the Consumer Defensive median of 24.2, and the peer comparison on this page calls the P/E a premium to peers. Its price-to-sales ratio of 9.72 is 341.8% above the sector median of 2.2.
MNST is growing faster than its sector: revenue rose 20.20% in the latest year, compared with a sector median of 5.3%. Profitability is strong, with a net margin of 23.08%, an operating margin of 29.18% and a return on equity of 25.70%, which sits above the sector median of 19.7%. On the balance sheet, debt-to-equity stands at 0.01.
MNST's most recent quarterly report, dated August 6, 2026, topped the estimate by 3.45%. EPS came in at $0.3, against the $0.29 analysts had expected. Even so, the share price dropped 4.04% in the next session.
The earnings record shows 4 beats in 7 reports, but beats have not guaranteed gains: the stock fell the next day after 1 of them. Looking ahead, analysts expect EPS of $1.15 this fiscal year (growth of 18.7%) and $1.31 the year after (growth of 13.5%).
At a P/E of 42.34, which sits 75.0% above the sector median, MNST is priced as a premium to peers. That leaves less room for any disappointment in future results to be absorbed. The average daily move is 1.35%.
MNST against the Consumer Defensive sector
How MNST compares with the median Consumer Defensive stock CleaRank tracks.
Price to earnings vs sector: MNST trades at a significant premium to sector peers (+75%), suggesting market expectations for superior growth or market position.
Return vs SPY: Since May 6, 2025, MNST has gained 52.4% against a gain of 36.6% for SPY.
Performance against SPY
MNST and the Consumer Defensive sector fund over the same days.
Revenue and earnings
How much MNST sells, and how much of it becomes profit.
Revenue growth: Revenue grew 10.7% in FY2025 to $8.3B, from $7.5B a year earlier.
Profit margin: The net margin was 23.0% in FY2025, up from 20.1% the year before.
Profitable: MNST earned $1.9B in FY2025.
Earnings reality check
Did MNST beat what analysts expected, and how did the stock react?
Earnings record: MNST beat the analyst estimate in 4 of the last 7 quarters.
Market reaction: The stock fell in the first session after 1 of those 4 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 6, 2026after close | $0.29 | $0.30 | +3.45% | -4.04% | -0.55% |
| May 7, 2026after close | $0.26 | $0.29 | +11.54% | +13.58% | +12.97% |
| Nov 6, 2025after close | $0.24 | $0.27 | +12.50% | +5.16% | +7.19% |
| Aug 7, 2025after close | $0.24 | $0.25 | +4.17% | +6.40% | +5.59% |
| May 8, 2025after close | $0.23 | $0.23 | +0.00% | +1.43% | +3.64% |
| Feb 27, 2025after close | $0.20 | $0.14 | -30.00% | +5.26% | +7.26% |
| Nov 7, 2024after close | $0.21 | $0.19 | -9.52% | -1.08% | +2.25% |
As of October 17, 2026, MNST has beaten the analyst EPS estimate in 4 of its last 7 reported quarters and fell in the first trading session after 1 of those beats; its latest report, on August 6, 2026, came in 3.45% above the estimate and the stock moved -4.04% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 62.6, showing bullish momentum without being overbought.RSI above 50 ›
An RSI of 62.6 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank AI analysis of MNST
The score, the reasoning behind it, and what could move the price next.
Monster Beverage Corporation (MNST) is in an uptrend. At $45.73, the price is 2.18% above its 50-day average of $44.76 and 7.24% above its 200-day average of $42.64. It trades near the top of its 52-week range, 8.85% below the high of $50.17 and 38.83% above the low of $32.94. The 50-day average is 4.96% above the 200-day, so the two averages are arranged in the order an uptrend would show.
The 14-day RSI of 62.6 is in the bullish zone, below the overbought line, and the MACD line is positive. The short and long run point different ways: the price rose 2.60% over the past month, fell 6.19% over the past three months and rose 30.36% over the past year. Volume in the last session ran 32.8% above its average, on a day the price rose 0.86%.
Earnings beat ›
The August 6, 2026 report beat the EPS estimate by 3.45%, and the share price fell 4.04% in the first session after it.
Source: Earnings report, August 6, 2026
Rating reaffirmed ›
Wells Fargo kept its Overweight rating on October 5, 2026.
Source: Analyst action, Wells Fargo, October 5, 2026
- Two levels matter most: the 52-week high of $50.17 above the price, and the 50-day SMA at $44.76 below it.
- With the 14-day RSI at 62.6, the momentum reading is bullish, and the MACD line is positive. Readings above 70 or below 30 would signal stretched momentum.
- After the August 6, 2026 report the share price fell 4.04% in the first session; MNST beat estimates in 4 of the last 7 reports.
The uptrend depends on MNST holding above its 50-day average of $44.76 and its 200-day average of $42.64. A close below the 50-day would be the first sign of that trend weakening. If the price pulls back, the 50-day SMA at $44.76 is the first level it would reach.
The next level overhead is the 52-week high of $50.17. The RSI sits in the bullish zone, which suggests momentum still supports the move higher.
Technical indicators
Momentum and trend for MNST, from its daily closes.
As of October 17, 2026, with MNST at $45.73, its 14-day RSI is 62.6 (showing bullish momentum without being overbought), its 50-day simple moving average is $44.76 and its 200-day is $42.64.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What MNST moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, MNST's 1-year correlation of daily returns is +0.21 with S&P 500 (SPY), +0.15 with Nasdaq 100 (QQQ), -0.03 with Bitcoin (BTC) and +0.09 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
14 of 25 analysts rate it a buy or strong buy, 10 a hold and 1 a sell.Median target above the price ›
The median 12-month target of $50.00 is 9.3% above the price.More buy ratings than three months ago ›
14 of 25 rate it a buy now, against 14 of 26 three months ago.
MNST Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 5, 2026 | Wells Fargo | Maintains | Overweight |
| Aug 7, 2026 | UBS | Maintains | Neutral |
| Aug 7, 2026 | RBC Capital | Maintains | Outperform |
| Aug 7, 2026 | Piper Sandler | Maintains | Overweight |
| Aug 7, 2026 | Evercore ISI Group | Maintains | Outperform |
| Jul 20, 2026 | BMO Capital | Maintains | Market Perform |
As of October 17, 2026, 25 Wall Street analysts cover MNST: 14 rate it a buy or strong buy, 10 a hold and 1 a sell or strong sell. Their 12-month price targets range from $35.00 to $57.00, with a median of $50.00, 9.3% above the price of $45.73.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
MNST trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from MNST's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much MNST tends to move, against the market and on its own.
The long record
MNST's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Average daily move under 2% ›
The price has moved 1.35% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 29.4%, from February 2018 to December 2018, regained by February 2020.Most 1-year holds ended higher ›
75% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $38,029, against $42,055 in the S&P 500 (SPY).
MNST Drawdowns & Recovery
As of October 17, 2026, MNST's worst peak-to-trough fall over the last 10 years with dividends reinvested was -29.4% (February 2018 to December 2018); it regained that peak by February 2020, 14 months after the low, and 75% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into MNST in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: MNST trailed the S&P 500 over this period: $38,029 against $42,055.
A $10,000 investment in MNST in October 2016 would be worth about $38,029 today with dividends reinvested, compared with about $42,055 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to MNST, and which have not.
Strongest month, November: an average of +6.24%, up in 9 of 10 years.
Weakest month, September: an average of -2.15%, up in 2 of 10 years.
This month, October: has averaged -1.54%, up in 4 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, MNST's strongest calendar month has been November (average +6.24%, up in 9 of 10 years) and its weakest September (average -2.15%, up in 2 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in MNST, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in MNST today could grow to about $23,791 by 2036 in the base case, with a 90th-percentile outcome near $69,389 and a 10th-percentile outcome around $8,157. Projections are statistical simulations, not guarantees.
MNST Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $64.68 for MNST by 2030 in the base case, from $45.73 today (1.4x over 4 years). The 10th-percentile path ends near $32.87. These are outcomes of a Monte Carlo simulation run on MNST's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $35.55 | $49.87 | $69.96 | |
| 2028 | $33.70 | $54.39 | $87.78 | |
| 2029 | $33.00 | $59.31 | $107 | |
| 2030 | $32.87 | $64.68 | $127 | |
| 2031 | $33.09 | $70.54 | $150 |
Method: a lognormal simulation of MNST's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
MNST insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought MNST shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 17, 2026, MNST insiders reported 12 open-market sales worth $39.3M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 14, 2026 | Hilton Hiller Schlosberg
Chief Executive Officer
|
Grant | 1.7K | - |
| Sep 3, 2026 | Rob L. Gehring
Officer
|
Grant | 20.0K | - |
| Jun 10, 2026 | Guy Carling
Officer
|
Sell | 19.0K | $1.7M |
| May 22, 2026 | Rodney Cyril Sacks
Director
|
Grant | 11.6K | - |
| May 22, 2026 | Hilton Hiller Schlosberg
Chief Executive Officer
|
Grant | 5.9K | - |
| May 14, 2026 | Emelie Tirre
Officer
|
Sell | 98.7K | $8.5M |
| May 14, 2026 | Mark J Hall
Director
|
Sell | 54.0K | $4.6M |
| May 14, 2026 | Mark J Hall
Director
|
Option | 54.0K | $2.6M |
| May 14, 2026 | Emelie Tirre
Officer
|
Option | 90.9K | $4.1M |
| May 13, 2026 | Thomas J Kelly
Chief Financial Officer
|
Sell | 7.0K | $614.7K |
| May 13, 2026 | Ana Demel
Director
|
Option | 2.7K | $236.1K |
| May 13, 2026 | James L. Dinkins
Director
|
Grant | 2.7K | - |
| May 13, 2026 | William W Douglas III
Director
|
Option | 2.7K | $236.1K |
| May 13, 2026 | Tiffany M Hall
Director
|
Option | 2.7K | $236.1K |
| May 13, 2026 | Jeanne P Jackson
Director
|
Option | 2.7K | $236.1K |
| May 13, 2026 | Steven G Pizula
Director
|
Option | 2.7K | $236.1K |
| May 13, 2026 | Mark S Vidergauz
Director
|
Grant | 2.7K | - |
| May 8, 2026 | Rodney Cyril Sacks
Director
|
Option | 16.9K | $599.8K |
| Mar 13, 2026 | Thomas J Kelly
Chief Financial Officer
|
Sell | 8.0K | $617.8K |
| Mar 13, 2026 | Guy Carling
Officer
|
Grant | 27.2K | - |
| Mar 13, 2026 | Guy Carling
Officer
|
Grant | 9.1K | - |
| Mar 13, 2026 | Rob L. Gehring
Officer
|
Grant | 1.1K | - |
| Mar 13, 2026 | Thomas J Kelly
Chief Financial Officer
|
Grant | 13.6K | - |
| Mar 13, 2026 | Thomas J Kelly
Chief Financial Officer
|
Grant | 3.3K | - |
| Mar 13, 2026 | Rodney Cyril Sacks
Director
|
Grant | 56.2K | - |
| Mar 13, 2026 | Rodney Cyril Sacks
Director
|
Grant | 270.4K | - |
| Mar 13, 2026 | Hilton Hiller Schlosberg
Chief Executive Officer
|
Grant | 270.4K | - |
| Mar 13, 2026 | Hilton Hiller Schlosberg
Chief Executive Officer
|
Grant | 63.4K | - |
| Mar 13, 2026 | Emelie Tirre
Officer
|
Grant | 27.2K | - |
| Mar 13, 2026 | Emelie Tirre
Officer
|
Grant | 9.1K | - |
| Mar 12, 2026 | Hilton Hiller Schlosberg
Chief Executive Officer
|
Grant | 1.1K | - |
| Dec 12, 2025 | Rodney Cyril Sacks
Director
|
Sell | 206.5K | $15.2M |
| Dec 12, 2025 | Emelie Tirre
Officer
|
Sell | 30.0K | $2.2M |
| Dec 12, 2025 | Rodney Cyril Sacks
Director
|
Grant | 13.5K | - |
| Nov 28, 2025 | Hilton Hiller Schlosberg
Chief Executive Officer
|
Grant | 8.9K | - |
| Nov 26, 2025 | Rodney Cyril Sacks
Director
|
Option | 611.0K | $14.1M |
| Nov 13, 2025 | Guy Carling
Officer
|
Sell | 38.4K | $2.7M |
| Nov 13, 2025 | Guy Carling
Officer
|
Option | 38.4K | $1.7M |
| Nov 11, 2025 | Hilton Hiller Schlosberg
Chief Executive Officer
|
Option | 630.0K | $13.9M |
| Sep 11, 2025 | Rodney Cyril Sacks
Director
|
Option | 630.0K | $13.9M |
| Sep 11, 2025 | Hilton Hiller Schlosberg
Chief Executive Officer
|
Grant | 1.1K | - |
| Sep 3, 2025 | Rob L. Gehring
Officer
|
Grant | 10.0K | - |
| Aug 13, 2025 | Mark S Vidergauz
Director
|
Sell | 10.0K | $637.3K |
| Jun 11, 2025 | Ana Demel
Director
|
Option | 3.6K | $224.8K |
| Jun 11, 2025 | James L. Dinkins
Director
|
Grant | 3.6K | - |
| Jun 11, 2025 | Gary P Fayard
Director
|
Option | 3.6K | $224.8K |
| Jun 11, 2025 | Tiffany M Hall
Director
|
Option | 3.6K | $224.8K |
| Jun 11, 2025 | Jeanne P Jackson
Director
|
Option | 3.6K | $224.8K |
| Jun 11, 2025 | Steven G Pizula
Director
|
Option | 3.6K | $224.8K |
| Jun 11, 2025 | Mark S Vidergauz
Director
|
Grant | 3.6K | - |
| May 30, 2025 | Hilton Hiller Schlosberg
Chief Executive Officer
|
Grant | 113 | - |
| May 29, 2025 | Thomas J Kelly
Chief Financial Officer
|
Sell | 27.0K | $1.7M |
| May 29, 2025 | Thomas J Kelly
Chief Financial Officer
|
Option | 24.0K | $1.0M |
| May 20, 2025 | Hilton Hiller Schlosberg
Chief Executive Officer
|
Grant | 10.9K | - |
| May 20, 2025 | Emelie Tirre
Officer
|
Option | 12.0K | $374.5K |
| May 16, 2025 | Emelie Tirre
Officer
|
Sell | 8.8K | $549.4K |
| May 14, 2025 | Mark S Vidergauz
Director
|
Sell | 3.5K | $212.2K |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.